Cargando…

The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis

BACKGROUND: There is a danger that mass drug administration campaigns may fail to maintain adequate treatment coverage to achieve lymphatic filariasis elimination. Hence, additional measures to suppress transmission might be needed to ensure the success of the Global Program for the Elimination of L...

Descripción completa

Detalles Bibliográficos
Autores principales: Burkot, TR, Durrheim, DN, Melrose, WD, Speare, R, Ichimori, K
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560133/
https://www.ncbi.nlm.nih.gov/pubmed/16914040
http://dx.doi.org/10.1186/1475-2883-5-10
_version_ 1782129471023742976
author Burkot, TR
Durrheim, DN
Melrose, WD
Speare, R
Ichimori, K
author_facet Burkot, TR
Durrheim, DN
Melrose, WD
Speare, R
Ichimori, K
author_sort Burkot, TR
collection PubMed
description BACKGROUND: There is a danger that mass drug administration campaigns may fail to maintain adequate treatment coverage to achieve lymphatic filariasis elimination. Hence, additional measures to suppress transmission might be needed to ensure the success of the Global Program for the Elimination of Lymphatic Filariasis. DISCUSSION: Vector control successfully eliminated lymphatic filariasis when implemented alone or with mass drug administration. Challenges to lymphatic filariasis elimination include uncertainty of the exact level and duration of microfilarial suppression required for elimination, the mobility of infected individuals, consistent non-participation of some infected individuals with mass drug administration, the possible development of anti-filarial drug resistance and treatment strategies in areas co-endemic with loasis. Integration of vector control with mass drug administration can address some of these challenges. The potential benefits of vector control would include: (1) the ability to suppress filariasis transmission without the need to identify all individual 'foci of infection'; (2) minimizing the risk of reestablishment of transmission from imported microfilaria positive individuals; and (3) decreasing the risk of dengue or malaria transmission where, respectively, Aedes or Anopheles are lymphatic filariasis vectors. SUMMARY: With adequate sustained treatment coverage, mass drug administration should meet the criteria for elimination of lymphatic filariasis. However, it may be difficult to sustain sufficiently high mass drug administration coverage to achieve lymphatic filariasis elimination in some areas, particularly, where Aedes species are the vectors. Since vector control was effective in controlling and even eliminating lymphatic filariasis transmission, integration of vector control with mass drug administration will ensure the sustainability of transmission suppression and thereby better ensure the success of national filariasis elimination programs. Although trials of some vector control interventions are needed, proven vector control strategies are ready for immediate integration with mass drug administration for many important vectors. Vector control is the only presently available additional lymphatic filariasis control measure with the potential for immediate implementation.
format Text
id pubmed-1560133
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15601332006-09-06 The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis Burkot, TR Durrheim, DN Melrose, WD Speare, R Ichimori, K Filaria J Perspectives BACKGROUND: There is a danger that mass drug administration campaigns may fail to maintain adequate treatment coverage to achieve lymphatic filariasis elimination. Hence, additional measures to suppress transmission might be needed to ensure the success of the Global Program for the Elimination of Lymphatic Filariasis. DISCUSSION: Vector control successfully eliminated lymphatic filariasis when implemented alone or with mass drug administration. Challenges to lymphatic filariasis elimination include uncertainty of the exact level and duration of microfilarial suppression required for elimination, the mobility of infected individuals, consistent non-participation of some infected individuals with mass drug administration, the possible development of anti-filarial drug resistance and treatment strategies in areas co-endemic with loasis. Integration of vector control with mass drug administration can address some of these challenges. The potential benefits of vector control would include: (1) the ability to suppress filariasis transmission without the need to identify all individual 'foci of infection'; (2) minimizing the risk of reestablishment of transmission from imported microfilaria positive individuals; and (3) decreasing the risk of dengue or malaria transmission where, respectively, Aedes or Anopheles are lymphatic filariasis vectors. SUMMARY: With adequate sustained treatment coverage, mass drug administration should meet the criteria for elimination of lymphatic filariasis. However, it may be difficult to sustain sufficiently high mass drug administration coverage to achieve lymphatic filariasis elimination in some areas, particularly, where Aedes species are the vectors. Since vector control was effective in controlling and even eliminating lymphatic filariasis transmission, integration of vector control with mass drug administration will ensure the sustainability of transmission suppression and thereby better ensure the success of national filariasis elimination programs. Although trials of some vector control interventions are needed, proven vector control strategies are ready for immediate integration with mass drug administration for many important vectors. Vector control is the only presently available additional lymphatic filariasis control measure with the potential for immediate implementation. BioMed Central 2006-08-16 /pmc/articles/PMC1560133/ /pubmed/16914040 http://dx.doi.org/10.1186/1475-2883-5-10 Text en Copyright © 2006 Burkot et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Perspectives
Burkot, TR
Durrheim, DN
Melrose, WD
Speare, R
Ichimori, K
The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis
title The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis
title_full The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis
title_fullStr The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis
title_full_unstemmed The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis
title_short The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis
title_sort argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560133/
https://www.ncbi.nlm.nih.gov/pubmed/16914040
http://dx.doi.org/10.1186/1475-2883-5-10
work_keys_str_mv AT burkottr theargumentforintegratingvectorcontrolwithmultipledrugadministrationcampaignstoensureeliminationoflymphaticfilariasis
AT durrheimdn theargumentforintegratingvectorcontrolwithmultipledrugadministrationcampaignstoensureeliminationoflymphaticfilariasis
AT melrosewd theargumentforintegratingvectorcontrolwithmultipledrugadministrationcampaignstoensureeliminationoflymphaticfilariasis
AT spearer theargumentforintegratingvectorcontrolwithmultipledrugadministrationcampaignstoensureeliminationoflymphaticfilariasis
AT ichimorik theargumentforintegratingvectorcontrolwithmultipledrugadministrationcampaignstoensureeliminationoflymphaticfilariasis
AT burkottr argumentforintegratingvectorcontrolwithmultipledrugadministrationcampaignstoensureeliminationoflymphaticfilariasis
AT durrheimdn argumentforintegratingvectorcontrolwithmultipledrugadministrationcampaignstoensureeliminationoflymphaticfilariasis
AT melrosewd argumentforintegratingvectorcontrolwithmultipledrugadministrationcampaignstoensureeliminationoflymphaticfilariasis
AT spearer argumentforintegratingvectorcontrolwithmultipledrugadministrationcampaignstoensureeliminationoflymphaticfilariasis
AT ichimorik argumentforintegratingvectorcontrolwithmultipledrugadministrationcampaignstoensureeliminationoflymphaticfilariasis